James Randolf in China Essay Example for Free

James Randolf in China Essay I. Overview The case focuses on James Randolf, a first-time expatriate manager from Controls Inc. He is sent abroad to help establish a joint venture (VC) with a Chinese subsidiary of the firm. Controls is a Chicago-based company which specializes in design of production of temperature control and filtration systems. Controls has already established operations in various parts of the world – Europe, Asia and South America. By investing in China, they are exploring the untapped Asian market, a key market with potential customers. Chong Ming Electro-Assembly is the company they are negotiating with in Shanghai. Despite the previous expansions of the US firm, the management has no experience working with Chinese firms before and they made a number of managerial mistakes that I am going to cover in this paper. But what the company did, was to negotiate an agreement with Chongming to jointly run a manufacturing plant on Chongming Dao island, north of Shangai. Controls sent James Randolf to co-manage the facility. J. Randolf was 51 years old at the time and had work in managerial positions in Engineering, Quality and Customer Support for 15 years. But what made him a perfect candidate for the position was that his wife was born in Shanghai. That made him the most culturally empathetic to his co-workers in the new facility. II. Preparation Prior to being sent to China, Randolf underwent an orientation training. There, points about his duties, obligations and assignments were discussed. The matter of payment was also settled, while his new position provided him with benefits such as convenient moving arrangements. Randolf then proceeded to visit the plant in Shanghai where he would be working for the next 3 years of his contract. Having committed to the assignment, he then received a supplemental orientation course which lasted 2 days. In this course he was supposed to become accustomed to the cultural differences of Chinese workers, to exchange information with other co-expatriates. All this supplemented with language learnings. Randolf then went on to work in the new facility for 13 months after which he was recalled to the home office by phone.

The Importance of Diversity in Education Essay -- Diversity in Educati

I worked within an Independent School System for 10 years. As I contemplated the idea of working towards my Master’s in Education I brought with me the idea of diversity in education and why facilitating different school systems is vital to a healthy society. â€Å"Not every youngster gets along well in the public school system.† (Cunningham, 171) said Pat McGeer of the Ministry of Education publication Education Today. This very statement was a cry from thousands of families throughout the province of British Columbia in the 1960s. (Sullivan, 1988) My argument for this paper is that for governments to be ethical and moral agents they must hear the voices of their constituents, even if they are a few; and then respond equitably and with fairness. This equity and fairness includes policies ensuring their legitimacy and funding to facilitate their diversity. This idea then led me to the whole debate of whether parents should have the choice between public and inde pendent education. This debate primarily came into existence with â€Å"The Independent Schools Support Act in 1977† (Sullivan, 1988); although historically the idea of funding two systems can be â€Å"traced as far back as the colonial era of British Columbia†¦Ã¢â‚¬ (Sullivan, 1988). For the purpose of this essay, I want to explore how government’s equitable treatment of constituents lends itself to â€Å"good† government. From my perspective, the growth of the Independent School system has come out of the willingness by government to recognize and provide funding, thus giving parents the choice. â€Å"Accessibility and choice† (Sullivan, 1988) in education are interconnected and without either one, schools struggle to remain a viable option. It wasn’t until the Royal Commission in 1987 th... ...rt K. (1977). Servant Leadership. In Larry C. Spears & Robert K. Greenleaf (Eds.) (25th Anniversary Ed.) Servant Leadership: A Journey Into The Nature of Legitimate Power and Greatness (87-95). New York: Paulist Press. Maxwell, John C. (1993). Developing The Leader Within You. Nashville: Thomas Nelson Publishers. Saul, John Ralston. (2008). A Fair Country: Telling Truths About Canada. New York: Penguin Group. Sullivan, Barty M. (1988). Royal Commission – Extract on Independent Schools. Federation of Independent School Associations. 8.C.2. The Universal Declaration of Human Rights Yukl, Gary. (2010). Leadership in Organizations (7th Ed.) New Jersey: Prentice Hall. (2001, January). A Luxury the People of BC Cannot Afford: A CUPE BC Backgrounder on Independent Schools. (2007, September 17) Ontario Votes 2007. Faith-based schools.

Anaylse “The Thing”

The old cover was published on the video tape of the film. The new cover was published on a DVD. The old covers was published by PolyGram company and the new one was published by Universal Studios. The intended audience for the old cover is people over the age of twelve. I know this because the certificate on the film is twelve. This is in contrast to the old one where the certificate is eighteen. This reflects the advancements of technology, cameras are more powerful and are superior than they were forty years ago and are capable of putting more affects in order to make the film to appear extra horrific. The old movie may not be suitable for over twelve because of it will require a long attention span and this shows that the movie is created for people who have longer attention spans. And the subject that is covered in the film will not be designed for under twelve's and they may loose interest. Both films are for people who are fond of science fiction (sci-fi). I think it is designed for the entertainment of both sexes and regardless of your level of education; you shouldn't have too much intricacy understanding both films. There are opinions on both of the covers. The purpose of the opinions is to persuade the reader to buy/watch film. All the opinions are positive and the effect this has is to make the reader think positive things about the film. On the old cover the opinion is â€Å"Howard Hawk's superb sic-fi thriller has become a huge cult classic and it is chilly as it is now as it was forty years ago†. â€Å"Chilly† is a play on word with two definitions it can indicate that it is very cold and also terrifying; both definitions apply to the text. The purpose of both texts is to persuade. It's a horror/sci fi so it has to appear to be bloodcurdling and the language should reflect this. Long sentences are used on both covers. The use of ellipses creates suspense and the reader would want to know more. Lots of alliteration is used throughout both texts. â€Å"Cult Classic† re-emphasizes the fact that the film is one of a kind and that it's not to be missed. â€Å"Strange Spaceship† and â€Å"Superb Sci fi† are also examples of alliteration, alliteration helps you to remember and it sounds better on the tongue. Alliteration can also aid in memory and it provides additional emphasis. The text is their to show the positive light and to persuade the reader to watch/buy the film. The producers of the film do this because their ultimate aim is to make profit. On both covers there are facts and opinion. Old Cover- â€Å"A government station near the North Pole detects the crash of an un-identifies object and asks the air force to investigate. Captain Hendry locates a strange spaceship and a mysterious figure is frozen in the ice† This is a fact as it tells the reader what is going to occur in the film. â€Å"Howards Hawks superb sic fi thriller† this is an opinion not everyone will think the same. On the new cover, â€Å"Horror meister John Carpenter (Halloween Escape from New York) teams Kurt Russels outstanding performance with incredible visuals to build the chilling version of the whole classic thing†~ This is a positive opinion of the film, this again is their to persuade the reader to purchase the film. This opinion also promotes the actor (Kurt Russels) and this in turn will make his fans wanting to watch the film. They use hyperbolic language when describing his acting as â€Å"outstanding†. John Carpenters name is frequently repeated and his high-quality horror making skills are re-emphasized frequently. â€Å"In the winter of 1982 a twelve man research at remote Antarctica research team at a remote Antarctic research Station discovers an alien buries in the snow for over 1,000,000 years†.~ This is a fact, it tells you what will occur in the film, and it makes it sound as appealing and alluring as possible. The use of the word â€Å"remote† makes you sympathize with them as they are alone and isolation with a terrifying monster/alien on the loose. There are various number of people quoted in the covers of the film. In the New cover â€Å"John Carpenter† is described as a â€Å"horror meister†. Film-fans who have viewed any of his previous films before and are a fan of his work also want to view this one. In the old cover Howard Hawk is described as producing a â€Å"superb sci fi thriller† and his previous films are used to his credit (they appear to be quite successful) so that is another favourable impression of the film. The writer is very pleasant, carefree and blithesome. His writing tone is very spirited and refreshing this is probably because they are not talking about a serious issue, they are promoting a film. They are bias because they are only focusing on the positive things about the film. I am sure the film is not flawless. What about the film critics what about the negative comments that they have made about the film? Kurt Russels outstanding performance† – not everyone will agree. The actors are illustrated on the both of the covers rather than the brains behind it all. On the new cover the illustration of a strange man with a beard on engages the viewer. This image is right next to the blurb. The slogan is â€Å"Man is the warmest place to hide†. There is mysterious image of someone (alien or human?) on the front cover with this person is faceless, and this again engages and captivates the viewer. The new cover has blue and white on it, perhaps this is a connotation for ice and arctic weather as it is freezing in the Antarctic. The title of the film (The Thing) is in very large bold print and it's in upper case letters. The old cover is mainly black and white and the text and title of the film is in red print. Red as colour is very bright and stands out especially when the background is back and white. Perhaps the colour red is a connotation for blood and danger. The alien is portrayed as being colossal compared to them and it's made to look very intimidating and threatening with very razor-sharp lengthy fingernails. For forty years ago the old cover would have almost certainly have been the finest for the time period. The fact that they wouldn't be as much competition as there is now than forty years ago would also help conspicuously. The cover of the new film is very extremely attractive and I would unquestionably be interested viewing it. The old cover perhaps the older generation would like to view. I prefer modern movies but then again this is a matter of personal opinion.

The Inner Turmoil Expressed in Brutus’ Soliloquy in...

Brutus’ soliloquy in William Shakespeare’s Julius Caesar reveals Brutus’ inner turmoil before he decides on participating in the conspiracy. Brutus is torn between his love for Rome and his friendship with Caesar. However, Brutus fears that Caesar’s tyranny after enthroning will cause harm to Rome and return Rome to dictatorship. In the end, Brutus chooses his obligation to Rome over Caesar. Brutus soliloquy reflects on his internal conflict between his love for Caesar and his fear of Caesars power and ambition in which Brutus eventually resolves to kill Caesar. Brutus’ affection towards Caesar makes him hesitate to kill Caesar. Brutus’ sorrow towards the idea of the conspiracy contributes to his disinclination of killing Caesar. Brutus has deep affection for Caesar, however he is pressured to eliminate Caesar because of his sense of duty to protect Rome, â€Å"And for my part/ I know no personal cause to spurn at him/ But for the general.â € (2.1.10-12) Brutus effectively uses the tone of helplessness to evoke pathos in the audience. The atmosphere of sympathy establishes Brutus’ unwillingness to kill Caesar. Furthermore, Brutus avoids the usage of Caesar’s name, as he feels shameful when convincing himself to kill Caesar. Brutus repeatedly uses third person pronoun ---- â€Å"he†. Instead of using Caesar’s name, Brutus, consciously or unconsciously, replaces it with a pronoun. Brutus’ diction establishes his awareness of his talk of the conspiracy against his best friend. He feelsShow MoreRelatedShakespeares Tragic Hero in The Tragedy of Julius Caesar Essay example1876 Words   |  8 Pageshundreds of years The Tragedy of Julius Caesar by William Shakespeare has been studied, reviewed, taught, read, and immortalized in films. Why would a voluminous amount of resources be poured into this simple play? As with Shakespeare’s other works, this play has been a great tool for E nglish majors, authors, and any interested to have an insight on human action and reason. The tragedy follows Cassius and Brutus, the protagonists, as they seek to overthrow Julius Caesar from monarchy in Rome. They plan

Changing us marketing stratges by pharmaceutical companies - Free Essay Example

Sample details Pages: 12 Words: 3653 Downloads: 1 Date added: 2017/06/26 Category Statistics Essay Did you like this example? Abstract Pharmaceutical companies spend large sums of money in the time-consuming research and development of new drugs and the new classes of drugs. Each company marketing in the US seeks the possible payoff of staggering high profits which is possible on their patented medicines. Because of the lack of price regulation in the marketing environment in the United States, the United States has become a premium sales market targeted by all pharmaceutical companies. Don’t waste time! Our writers will create an original "Changing us marketing stratges by pharmaceutical companies" essay for you Create order This explains the continued willingness of each pharmaceutical company to persist through the entire long process of idea, creation, development, testing, approval, marketing and distribution despite the high possibility of product failure. The pharmaceutical companies have had to additionally contend with more US federal FDA rules, regulation and oversight in the United States for the entire process before receiving clearance to start marketing their drug product. Other influences like HMOs and Social Security cap limits affect profitability structure. Over the last fifty years newer marketing strategies by pharmaceutical companies on prescription drugs include a directive appeal to the end consumer to increase the odds of making corporate profits and a marketing focus on social and internet interaction. Introduction Pharmaceutical companies produce specialized medical drug material designed to fill a need. These pharmaceutical companies are usually multinational operations located in key countries around the globe. Many have grown to become complete facilities that attempt to do the entire spectrum of research, develop, test and finally market the subject drug in order to reap the whole benefits possible from the entire cycle (Kaitin, 2010). The pharmaceutical industry has shown over time that they have the capability to increase consumer perceived value with their unique drug products using their own successful plans for timely marketing. But because of these old and new factors causing cumulative hurtles, a new trend in marketing in the pharmaceutical industry is now to additionally market direct to the customer, for example: TV advertising spots showing a new superior drug product which has special features making it directly appealing to a consumer. Changes in basic marketing structure tacti cs will be evaluated for the key levels of pressure from these internal and external factors as these pharmaceutical companies seek to address continuing ongoing product failure rates, increasing US regulation and the ever present potential competition from others inside their own industry. This trend has been a natural development over the last hundred years or so. This is reasonable because the same research that produces one drug may produce an entire class of drugs for market. Confidentiality, control, patents and oversight give these pharmaceutical companies the oversight. It also allows each pharmaceutical company to keep maximum control of all their connected environments. And by controlling these the final marketing each company achieve continues the cycle of giving the most control over the drug for the marketing campaign. The drug industry often competes worldwide and on different economic levels but in some specific territorial markets like the United States, pricing structures are not preset by the government and therefore the free market sets its own competitive standards for pricing giving the possibility and most often the probability of higher drug prices with the resultant bigger profit level opportunities. However these are offset by rigorous structural standard guidelines set by the FDA that must be complied with for any drug sold or marketed to the US public. In the past, drug companies in United States, marketed to doctors, hospitals, nursing homes and sometimes middleman companies as transitional handlers of the newest product. Marketing drugs in the United states has now changed as developers are now targeting consumers directly through television spots, online advertising and in print ads. The direct appeal is to make the end point consumer aware of the name of the drug and its benefits. The object is to have the consumer become familiar with the trade name, ask for the drug directly from their doctor thus boosting the initial sales of the new product and creating a ready market. Industry History Marchetti Schellens (2007) outline the structures of development showing it to be complex and expensive. Not only does the potential class or specific drug have to be discovered or created, it has to show promise for certain illness or disease, then pharmaceutical research can proceed through certain phases. Pharmaceutical companies have a history of costly product failures. Generally theres three clinical phrases and all this can take upwards of 15 years to complete. Additionally the FDA has trended over the last decade to creating higher pressures against drug companies by not approving as many new drugs for marketing. The probability odds are that any specific drug in early clinical phase has only 8% chance or less of ever becoming public (Food and Drug Administration, 2006) (Kummar, 2007). In the United States the U.S. Food and Drug Administration (FDA) has sought to control the drugs available to Americans because of the number of tragedies that have resulted in birth defects o r deaths. The most highly publicized incident was in the mid-1960s and the drug was called thalidomide which for pregnant women often resulted in severe birth defects. As an end result of public outrage creating governmental pressures, the pharmaceutical companies are overseen at all levels and must now successful clinical trials. Lamb(1998) writes that testing protocols have been standardized and once clinical trials are completed there is a analysis period with the end result being an application to the FDA called an NDA ( new drug application) which contains all the technical information. Over the last forty years (1970s -2010) and now in 2011 differential forces are in opposition to the ends of pharmaceutical companies. Environmental and safety issues, new technologies, mergers and the rise of managed care and health maintenance organizations (HMOs) have all effectively changed the environment thats pharmaceutical companies operate in. additionally in 1997 the FDA changed regulations relating to the presentation of risk level. This action in the United States opened the door for pharmaceutical companies to directly market to the public .This freedom for the pharmaceutical companies is offset by the FDA still having oversight surveillance of the specific phases and clinical approval. The FDA must approve the drug. After the drug is marketed there is oversight for continued compliance by the pharmaceutical companies to ensure a low-level of side effects during marketing. Post approval by the FDA comes solely after this period (Silverman, 2011). Pharmaceutical company spending on marketing exceeds that spent on research.[3][22] In 2004 in Canada $1.7 billion a year was spent marketing drugs to physicians and in the United States $21 billion were spent in 2002.[4] In 2005 money spent on pharmaceutical marketing in the US was estimated at $29.9 billion with one estimate as high as $57 billion.[3] When the US number are broken down 56% was free samples, 25% was detailing of physicians, 12.5% was direct to consumer advertising, 4% on hospital detailing, and 2% on journal ads.[4] In the United States approximately $20 billion could be saved if generics were used instead of equivalent brand name products.[3] Although pharmaceutical companies have made large investments in marketing their products, overall promotional spending has been decreasing over the last few years, and declined by 10 percent from 2009 to 2010. Pharmaceutical companies are cutting back mostly in detailing and sampling, while spending in mailings and print advertising grew since last year.[23] Historical Marketing Pharmaceutical companies have employed various methods of marketing their products and this idea can be understood by the phrase How would you like to be in an industry where your buyers are uninformed about your product and almost 100 per cent insensitive to its price? (The Business Edge Consortium, 2010). For many decades this was true. Around the mid 80s this started to change The result of these industry conditions was impressive profit growth through the middle of the 1980s. With significant barriers to entry, docile suppliers, powerless buyers, almost no threat of substitutes, and little rivalry, the pharmaceutical industry in the 1980s was just about as perfect an industry as one could imagine. Given its attractiveness, the industry attracted the attention of genetic and molecular biology scientists and the venture capital community, who saw its appeal and thought their revolutionary approaches to drug therapy could attract enough money to overcome the formidable entry barrier s the industry enjoyed. Thus, as scientific advances in biotechnology took hold, numerous entrepreneurial companies like Genentech and Amgen were founded to commercialize new scientific breakthroughs. Genentech, the first biotech firm having commercial success, developed a protein that broke up blood clots. Amgens famous molecular biology used recombinant DNA to produce erythropoietin, a hormone that increases the supply of red blood cells in anaemic patients under treatment for cancer and other diseases. By 2000, erythropoietin was generating $2 billion in sales and another $3 billion in licensing revenue for Amgen. Both of these new entrants fared very well in this attractive industry:Genentech went public in 1980, and by 2001 its shares had appreciated 2700 per cent since its IPO. Amgen shares, first offered in 1983, soared more than 16,000 per cent. Starting in the mid-1980s, the barriers to enter the pharmaceutical industry began to show cracks. New legislation made it easier for generic drug companies to enter the market. In the USA, the 1984 Waxman-Hatch Act, which changed the rules for generic drug manufacturers, reduced the barriers to generic entry. Instead of having to prove the generic drugs safety and efficacy, the act required companies only to prove their formulas were equivalent to that of the brandname drug. The subsequent growth in generic drugs was profound. By 1996, generic drugs accounted for more than 40 per cent of pharmaceutical prescriptions. Aside from the influx of generics, the pharmaceutical companies also saw a wave of biotechnology competitors enter their industry Genentech, Amgen and many others suggesting that economies of scale meant less than they used to, and that barriers to entry, while still high in absolute terms, were dropping, thanks in part to the availability of venture capital. Further, the biotech companies new science-focused research model, known as rational drug design, stood the traditional approach to drug discovery on its head. These drug companies worked backwards from known disease biochemistry to identify or design chemical keys to fit the biochemical locks of that disease. Traditionally they employed very effective strategies that includes educational sponsorship to cover the costs of continuing instruction for top medical personnel, sponsorship of articles in well-respected journal publications, providing free drugs samples to doctors and promotional gifts that include a corporate logo or specifics about a drug the idea behind the promotional marketing is to simply connect the new drug with an old medical symptom and encourage the writers of the prescription to fulfill the marketing cycle. Promantally pharmaceutical samples are still given out to doctors as a promotion and marketing tactic and it works (Alexander, Zhang Basu, 2008). A few generations ago these forms of marketing worked well for the pharmaceutical companies. However circumstances have changed. The FDA seeks to discourage the intimate connection between pharmaceutical companies and their pharmaceutical representatives is the connection to the doctors prescribing medicines, these days d octors see more patients and fewer pharmacy drug representatives, additionally there is a continuing trend by hospitals, doctors and pharmacies towards being conservative in their recommendations and prescriptions because of lawsuits of all kinds (Pharmaceutical Industry History, 2007). Medical drug malpractice suits in the US are rising. Fiscus (2008) writes that In the United States, the growing use of DTC advertising has raised challenges to one of the strongest defenses available to drug manufacturers against failure to warn allegations in product liability suits for prescription drugs and medical devices: the learned intermediary doctrine. Under this doctrine, a manufacturer fulfills its duty to warn by adequately informing a learned intermediary, typically a physician. Current Marketing .In 2010 the global pharmaceutical market is worth over 825 million with a large percentage of this comes from newer and mature drug products and there are over 100,000 health-related websites (The Business Edge Consortium, 2010). The statistics show that marketing by pharmaceutical companies is changing because of external pressures. There has been a dramatic rise in U.S. physicians routinely using d the web to check or research information making the relevance of digital promotion all the more important Pharmaceutical companies have risen to the changing challenge of Internet marketing and now promote and advertise doctor friendly physician and customer service online portals like PubMed, the U.S. National Library of Medicine, National, and Physicians Interactive (Kaitin, 2010). Pharmaceutical marketers are relying more on connecting digital medical information to their target audience through focused marketing, interactive social media campaigns, and cell and mobile linked advertising all targeted to connect to the 145 million + U.S. adults who go online for health answers . The old saying time is money is accurate in the case of pharmaceutical companies as it takes upwards of 15 years to develop a potential drug which only has a 8% probability of getting out of trials and going to market. Therefore it is a necessity to carefully control costs and expenses where possible. One major area of expense has been having marketing representatives which were costing out as high as15 to 20% of a pharmaceutical companies annual drug product revenues. As pharmaceutical company overall expenses and costs have additionally escalated over the last few generations there is a need to reduce expenses down where possible. So the switch from costly pharmaceutical representatives to cheaper graphic marketing is easily understood. Finkelstein (1997) wrote that Competitive and technological changes in the pharmaceutical industry-from powerful new drug chemistries to innovative RD partnerships and marketing plans-are reshaping the business strategies of many pharmaceutical and biotechnology companies Given these cost pressures it is understandable that the pharmaceutical companies are looking for better ways to market their drugs. The newest strategy is now to promote what is known as marketing blockbuster medical drugs directly to the consumer public. The idea was to empower the consumer. Right now only the United States and New Zealand allow pharmaceutical products promoted by DTC (Pharmaceutical Drug Manufacturers, 2011). When an individual consumer requests information and the medicine by name by their Doctor some of the responsibility while also applying pressure on the doctor to prescribe the new medicine. Additionally both the small and large pharmaceutical companies are now using digital media to promote their products. From TV and cable to Internet ads consumers are constantly being made aware of the virtues and minor drawbacks of a number specific pharmaceutical drugs. The reasoning behind this strategy by the pharmaceutical companies is relatively simple, if they can promote their products and make its trade name and cure synonymous with the ongoing medical complaint in the publics mind, then they can create momentum utilizing the end customer. Another reason for doing this is to get any of their major blockbuster drugs to pay for the company costs for their other company made drugs sold in smaller volumes Another reason for marketing these blockbuster drugs as to make a success of these drugs synonymous with the company name creating consumer goodwill towards the next product. The latest trend is for reduction in the number of blockbuster drugs and pharmaceutical companies delvin g back into their former research to find potential missing new specialized drugs, .this can be seen clearly by the reduction in applications to the FDA showing ever reducing numbers of new drugs. Another complication that pharmaceutical companies must contend with is the ever-growing number of over-the-counter substitutes (OTCs) that the consumers choose to purchase as an alternative. Over a period of 20 years Naprosyn was widely prescribed as an arthritis remedy but now is available as an over-the-counter drug. A whole spectrum of drugs from arthritis to antihistamines are now available without prescription providing relief to customers but adding little to the economic bottom line of pharmaceutical companies that originally developed these drugs. Another complication in drug marketing is the force exerted by HMOs on doctors and what doctors prescribe .Generally the majority of HMOs are not big on covering high prescription costs for new medicines recently brought to market. The economics are easily understandable because it is not about a single client which needs a single drug but the numbers are multiplied by the potential hundreds of thousands. Therefore HMOs seek to be conservative. And because of that they create a potential customer roadblock for pharmaceutical companies with the new drug on the market at a very high price. Because of the HMO will not cove r the price then the customer must, which generally means the consumer settles for less than the newest product. managed care organizations (MCO), compared with 5 per cent of the US population covered in 1980. These MCOs typically provided full coverage for prescription drugs. But, because of their sheer mass, these institutions had considerable bargaining power with drug companies If present industry overview is taken into consideration then the global pharmaceutical market in 2010 is projected to grow 4 6% exceeding $825 billion. The global pharmaceutical market sales is expected to grow at a 4 7% compound annual growth rate (CAGR) through 2013. This industry growth is driven by stronger near-term growth in the US market and is based on the global macroeconomy, the changing combination of innovative and mature products apart from the rising influence of healthcare access and funding on market demand. Global pharmaceutical market value is expected to expand to $975+ billion by 2013. Different regions of the world will influence the pharmaceutical industry trends in different ways. https://www.da-group.co.uk/index.php?option=com_contentview=articleid=31%3Amicro-and-macro-environmentscatid=2%3Amarketing-lecturesItemid=3 CURRENT CHALLENGES FOR THE RESEARCH-BASED INDUSTRY To understand why business as usual is no longer an option for the research-based drug industry, it is worth considering some of the myriad challenges that drug companies currently face. At the top of the list is the upcoming onslaught of patent expirations of many highrevenue- generating branded medicines. Between 2009 and 2012, worldwide sales for these products will exceed $112 billion (Table 1). Included in this list are 36 blockbusters (drugs with annual sales of $1 billion or more). Some important examples include Singulair (montelukast), with more than $4 billion in annual sales (patent expiration in 2012); Plavix (clopidogrel), with more than $8 billion in annual sales (patent expiration in 2011); and Lipitor (atorvastatin), with an industry-leading $13.7 billion in annual sales (patent expiration in 2010). Given that only 3 in 10 new products, on average, generate revenues equal to or greater than average industry RD costs,1 the loss of patent protection on these blockbuster s represents a very real threat to the industrys ability to sustain its own growth. Without question, many of the large pharma mergers and acquisitions announced in 2009 reflect the industrys desire to avoid the imminent danger of the patent cliff, rather than an interest in enhancing RD capabilities or scope. The current environment for innovation presents formidable economic, regulatory, and political challenges for the research-based pharmaceutical industry. In particular, the growing time, cost, and risk related to drug development are stubborn obstacles to filling industry pipelines and boosting the output of new pharmaceutical and biological products. Presented here is a model of an innovation network. Although structures may vary, the innovation network offers the best mechanism to ensure viability and economic success for all sectors of the pharmaceutical and biotechnology industry, as well as the uninterrupted flow of innovative lifesaving and life-improving medicines for waiting patients. The Rise of Contract Research Organizations Clinical trials are administered by investigators at hospitals, academic institutions or managed sites. The investigators find and enroll healthy and symptomatic volunteers, each of whom is required to sign an informed consent acknowledging acceptance of the drug and its potential side effects. The testing protocol and informed consent form are monitored by Institutional Review Boards (IRBs) in the sites where the trials are conducted. In essence, the IRB acts as an ethics committee to ensure the safety of patients and volunteers. Once clinical trials are completed, the data are subjected to biostatistical analysis over a 6 to 12 month period.3 If the data yield promising results, the sponsor seeks final approval though a New Drug Application (NDA). The NDA must contain all scientific information the sponsor has gathered and typically fills 100,000 pages or more.4 During the review period, the FDA assesses the safety and effectiveness of th e drug, the manufacturing process, and the risk-benefit calculus.5 By law, the FDA has 180 days to either approve the application or notify the sponsor of the opportunity to request a hearing on the merits of the application.6 In practice, however, the FDA review process takes more than two years; in 1996, for example, the mean approval time for NDAs was 17.8 months, down from over 30 months during the late 1980s.7 Following approval, the FDA may require additional post-market research. Post-market surveillance regulations require the sponsor to collect and periodically report additional safety and efficacy data.8 In addition, the FDA may request further clinical research (Phase IV) to find new uses for the drug, test dosage formulations, compare the drug to competitors treatments, and assess long-term effects.9 Finally, pharmaceutical Conclusions A continuous call for ethical standards by pharmaceutical companies that market in the United States is often put aside because company marketing and business model of making profits matter more.(Pharmaceutical Drug Manufacturer, 2011). Brezis (2008) writes that the US public will lose out in the long run because the pharmaceutical companies are more focused on marketing and profits than about public health. Drug trial deaths still happen and have been described as a trade secret. It is not just one of the big pharmaceutical companies by Johnson Johnson, Merick and others whose own safety documents raise concerns that are buried in stacks of papers while marketing continues (Brezis, 2008). But this is offset by the ability of both the doctor and patient to use the Internet to search out the detailed information and become truly informed. Each of them can then make an informed decision about the benefits and potential drawbacks of using pharmaceuticals.

The Mind Body Issue Is The Subject Of Extraordinary Debate

Rationalists and researchers have talked about the mind-body issue for a long time. The essence of the mind-body issue is that people have a subjective affair of an internal life or awareness that appears to be expelled from the physical world. In spite of a subjective affair of a partition amongst psyche and body, brain and body need to interface somehow. Precisely how the psyche and body associate is the subject of extraordinary debate. Toward the start of this course, I realized that my perspectives on the mind-body issue inclined more toward monism, however I didn t have a reasonable method of reasoning for my position. Given the many-sided quality of the mind-body issue, I expected that both dualism and monism would have†¦show more content†¦In the previous couple of decades, the field of brain research has propelled more neurochemical etiologies of mental issue, and Descartes dualism couldn t clarify how a neurochemical variation from the norm harms the non-physical p ersonality (Churchland, 1988). At long last, dualism is not a testable speculation (Cofer, 2002), and in this manner I can t acknowledge it as logical. The monist position, particularly monist realism, evades a large number of the previously mentioned imperfections of dualism. Monist realism keeps up that every single subjective state, for example, cognizance, can be lessened to neuronal movement. Individuals with religious feelings may observe monist realism to be shocking, on the grounds that diminishing awareness to a neural mark ruins the idea of through and through freedom. In any case, late research demonstrates that cerebrum action and muscle development go before cognizant basic leadership, which plainly bolsters monist realism (Libet, Gleason, Wright, and Pearl, 1983). Since I am not a religious individual, I do disagree with monist realism s position on choice. As far as awareness, I didn t surmise that any of the relegated savants made an extraordinary showing with regards to clarifying why cognizance could by no means be the result of neurons and neurotransmitters. I believed that John Searle verbalized the monist realis t position soundly, in that awareness is spatially confined to the cerebrum. Indeed, DavidShow MoreRelatedThe Current Scenario Of Water Wars Essay1325 Words   |  6 Pagesand we don’t even bother to talk about those issues. Where we talk about the â€Å"Make in India† programme and discuss about the development of our economy in international market. We have forgotten about the problem of scarcity of water which has been taking place in our country and also around the world. In this paper we will focus on the current scenario of water wars which is going nationally and internationally. The 1st thing that comes to one’s mind when we say the word water is ‘Life’. Our motherRead MoreReligious Views On Euthanasia And Assisted Suicide1528 Words   |  7 Pagestime. The debate has arisen as to whether people have the â€Å"right to die† or often referred to dying with their dignity. The modern dictionary defines the right to die as, â€Å"a person s right to refuse extraordinary life-sustaining measures intended to prolong life artificially when the person is deemed by his or her physicians to be terminally or incurably ill†(right-to-die). As the questions circling these methods of killing grow, religious groups are beginning to take stances on the issue. Two ofRead MoreInvestigating The Expository Qualification And The Debate Between The Personalistic And Naturalistic Position1574 Words   |  7 PagesThe objective of this task is to investigate the expository qualification and the debate between the Personalistic and Naturalistic pos ition in the originations of experimental history in psychological research, it likewise clarified the correlation between the two ideas and how the zeitgeist secured the associations with each of these ideas. Zeitgeist portrays as the â€Å"spirit of the time† and amid the seventeenth and nineteenth hundreds of years. On the occasion of the recorded advancement of exploratoryRead MorePhysician Assisted Suicide Or Euthanasia1597 Words   |  7 Pagesor euthanasia should be a right granted to all citizens who are suffering from a degenerative, painful, or fatal condition that would cause them to be unable to enjoy their lives as healthy people do. The right to die with dignity is a fundamental issue that is debated in the spiritual side of everyone. Some of us may have known someone close to them who has seen or gone through an ordeal as watching someone take their last breath. No one should suffer in pain or have their dignity taken from themRead MoreProtest Movement Of So uth Korea1404 Words   |  6 Pagessparked a wider movement towards a candid model of democratization. These protests climaxed in the nation-wide demonstrations that took place on the 19th of April – commonly cited as the ‘4.19’ protests. The results of these demonstrations were extraordinary, and largely account for the collapse of Syngman Rhee’s robust rule which had been in place since 1948. Historical considerations It is beyond the scope of this text to explore all of the historically significant events that shaped the sociopoliticalRead MoreThe Most Important Achievement Of The United States Essay1626 Words   |  7 PagesFreedom Very few United States Presidents can be truly called extraordinary. It is not only remarkable historical achievements during their tenure in office, but their relevancy to the United States throughout the ages that makes them truly great. It is incredible leadership and vision which indelibly shape a nation that establishes an extraordinary President. Abraham Lincoln is such a President. Lincoln reached into the hearts and minds of the citizens of the United States as no other President inRead MorePublic Perception of Feminist Performance Activism1927 Words   |  8 Pagesmass media, these feminist demonstrations in both Emily Anderson’s â€Å"Treacherous Pin-ups, Politicized Prostitutes, and Activist Betrayals: Jane Fonda’s Body is Hollywood and Hanoi,† and Kutz-Flamebaun’s article, are socially unaccepted in which their actions are deemed as a violation of female norm. However, without the media support, these extraordinary performances, such as Suzza nne Lacy’s visceral performance, as examined by Vivien Green Fryd’s article, â€Å"Suzanne Lacy’s Three Weeks in May: FeministRead MoreGenetically Modified Genes And Cells1598 Words   |  7 Pageswhich would kill all other plants. Monsanto issued licenses for the use of Roundup. Schmeiser, a farmer, never purchased Roundup Ready Canola nor did he have a license to plant it, yet in 1998 his fields contained 95-98% Roundup Ready plants. The issue before the court was the patent’s validity. Since all parties agreed that the patent was valid for the gene, the process of insertion and the cell derived from the process, the question was whether the patent covered the plant that is generated fromRead MoreEssay on The Charismatic Gifts3471 Words   |  14 PagesCHARISMATIC GIFTS: THEIR USE, FUNCTION,AND CONTINUITY Joseph Oliveri Bible 364 - Acts August 16, 2013 Introduction Their is much debate surrounding the use of the charismatic gifts in Acts. Many questions arise about how to use such gifts, and whether or not they can be used today in the first place. The debate regarding the continuation and the cessation of the spiritual gifts, the meaning of which we will clarify in a moment, is a relatively modern one. Although weRead MoreA Short Note On Body Scanner And Its Effects On The Dynamic, Security, And Privacy1916 Words   |  8 PagesI. INTRODUCTION: A full – body scanner is a device that used to capture an image of a person through their clothing to examine concealed objects without making any physical contact. These devices are being adopted at Airports in many countries. AIT assumes a critical part in Transportation Security Administration and the choice about its advantages involve open intrigue. The Technology has created a substantial debate that these are unsafe, ethical, security, and violate privacy and civil liberty

Corporate on Employee Upskill

Question: Describe about the Upskills. Answer: Introduction Upskilling employees is one of the most crucial and integral processes of organization. This research will focus on the topic "corporate on employee Upskill. In this context a case of IBM which is one of the giant multinational has been highlighted. This research has shown that how upskilling of the employees can help in improving the performance of the company. Up skilling the employees is a process of training of the employees so that they can acquire additional skills to perform their work effectively. It has become an integral part of many of the successful companies. Up skilling the employees will help IBM in competing and surviving in a highly volatile and dynamic market. This research will also provide deep insights about how to implement the plan of upskilling of the employees in a way that all the needs of employees can meet in the most effective manner. This research will firstly define the actual problem that the company is facing along with the action that can be taken by the organization. Then the advantages and disadvantages of upskilling of the employees will be discussed along with recommending the ways in the company can upskill its employees. An implementation plan will also be discussed. This research will be one of the major contribution in understanding the importance and role of employee upskilling. Problem Definition Lack of skills among the employees is one of the major concerns of the organizations. The skills of the employees are one of the most important elements of an organization that helps in attaining productivity and increased revenue. IBM, one of the business giants is experiencing a dip in the revenue since the year 2015. The senior management of the organization realized that the employees with lack of additional marketing skills that are essential to compete in a highly dynamic and competitive market. The marketing and sales professionals were not able to plot and implement different strategies that were essential in context of surviving in information technology business. The company is facing huge losses despite of offering some of the best products and services. Moreover the sales and marketing professionals of the company are also de motivated by the fall in the companys revenue because of their performance. The company soon has to realize that it is a big problem that needs an i mmediate action(IBS Center for Management Research , 2016). Company Profile IBM is one of the companies that focus on the development of the employees. International Business Machines Corporation referred as IBM is an American multinational technology company that is headquartered in Armonk, New York, United States. The company operates in more than 170 countries. The company was founded in the year 1911 as CTR (Computing-Tabulating-Recording Company). In the year 1924, the company was renamed as "International Business Machines". The company manufactures and markets the hardware, middleware and software along with offering the hosting and consulting services in all the areas associated with mainframe to nanotechnology. In addition the company also known is to be one of the major research organizations that hold the record of number of patents. The major inventions of the company include floppy disk, hard disk, automated teller machine (ATM), the magnetic stripe card, the SQL programming language, dynamic random-access memory (DRAM) and the UPC barcode(IBM, 2016). Action Defined Upskilling is particularly important for improving the performance and productivity of employees. To meet the challenges associated with dipping revenue because of the level of skills of the employees leaders must look for the solutions that develop the skill base of the employees. The ultimate solution is building the skills internally or up skilling the employees. The best practices associated with fostering the continuous learning have to be adopted so as to create an environment where intellectual capital can be easily diffused and shared among the employees. Despite the costs involved in up skilling the employees, it has become one of the most valuable processes that can help in improving the productivity, revenue and engagement level of the employees(Huddleston, 2015). Upskilling the employees directly contribute in the bottom line. For example: if additional skills are provided to the sales team in context of the closing techniques can eventually help in increasing the closing rates of the company. The benefits of upskilling the employees will extend to middle office positions(Bort, 2016). Upside/Downside There are number of upsides of upskilling the employees. The degree of employee productivity can be improved. The performance and engagement level of the employees can also increases. Also, company can achieve a higher degree of employee retention is achieved. In addition, more skills offer the employees a rewarding career and it fosters positive relationship between superiors and the subordinates. Company may also be benefitted by increased revenues and better position in the market(Noe, 2002). However, as every coin has two sides, upskilling the employees is also associated with some negative aspects. The cost involved in upskilling the employees is often high therefore many of the organizations choose not to upskill the employees and use their existing skills. Also, return on investment of upskilling the employees if often unknown. In addition, finding a right provider of the skill is another important concerns of upskilling the employees(National Industry Skill Commitee, 2014). Result Defined The result of upskilling the employees will extend from personal development of the employees to organization development. The pool of skilled employees of the organizations will be able to compete in the dynamic corporate world by achieving the complex targets and objectives. The value of upskilling is very high as the employees will be able to perform in the most effective way along with gaining a sense of accomplishment. The impact of upskilling the employees are for long term and the employees will be continuously motivated to contribute in the overall success of the organization. Employees are the major assets of the organization, anything done to improve their skills will benefit the organization in number of ways(Resilium, 2016). Recommendations The skill advancement of the employees should follow some important aspects. There are some recommendations that can be useful for IBM in context of upskilling the employees and improving the overall performance of the organization. The recommendations are discussed below: The company should identify the area that needs to build additional skills among the employees, so that the upskilling programs can match the actual need of the employees. This step is the first and most crucial step of the overall action plan. The company should then focus on finding the skill providers. These will be the trainers who are actually involved in the process of training and educating the employees. The right skill provider will help the company in training its marketing professionals and sales professionals effectively. The company should however find the skill provider only after the skill development needs of the employees are identified. The company should prepare the employees for the development of additional skills. This is done so as to ensure that employees do not lose interest in their present job. This step is essential in context of keeping the employees active along with encouraging them to clear their doubts and questions associated with skill development (Upskill America, 2014). The company should explain and demonstrate the skill development tasks and activities. The skill developers should explain the importance of the skills along with demonstrating the skills so that employees can effectively involve in the overall process of skill development. The repetitive practices will help the employees in acquiring more skills in a fast pace. The company should at last take the feedback of the employees in context of acquiring the marketing and sales techniques that can help them in improving the closing rates of the company. This is the last step of upskilling the employees at IBM. The feedback of the trainees is important in context of determining the effectiveness of overall program. Nestle, one of the food giants has followed the recommendations and the steps mentioned above to improve the sales. Nestle focused on upskilling its marketing and sales professionals when most of the market was captured by Cadbury. The recommendations mentioned above proved to be highly effective for Nestle after upskilling the employees the performance of the marketing and professionals was improved comparatively in terms of targets(Nestle, 2016). Implementation Plan An implementation plan helps in implementing the skill advancement plan effectively. In order to upskill the employees IBM will be requiring an effective implementation plan. One of the best implementation plans for IBM is given below: Identifying the needs of the employees in context of skill development is one of the most important steps of the implementation plan that has to be followed by IBM. The open communication sessions and performance reviews will help the company to identify the needs. Then the company should focus on finding the training provider along with scheduling the sessions. After the company schedules the session it should then focus on running the classes and ensuring that employees clear their doubts and questions associated with the skill development. At last IBM should focus on colleting the feedback from the employees(Bickerton, 2015). Budget Resources Required Human Resources Role Duration Effort Estimated Total Project manager/ Instructional designer 3 months 10 hours per week 500,000 Writer/Editor 2 months 5 hours per week 300000 Content experts 2 months 5 hours per week 240,000 Graphic designer 2 months 5hours per week 400,000 Administrative 3 months 5 hours per week 300,000 Trainers 3 months 8 hours per week 100,000 Total cost Conclusion The process of upskilling the employees has become one of the most important and integral processes of the most successful organizations. Upskilling the employees will help in improving the overall performance of the employees along with increasing the success rates of the organization In order to improve the sales of the company IBM must develop the skills of its marketing and sales professionals. The recommendations and action plan given in this paper will help IBM in upskilling the employees effectively. References Bickerton, P. (2015, September 5). How Upskilling Your Staff Saves Cash In The Long Run. Retrieved sept 5, 2016, from Saxons Group: https://www.saxonsgroup.com.au/blog/human-resources/how-upskilling-your-staff-saves-cash-in-the-long-run/ Bort, J. (2016, September 5). IBM Is Using An Unusual New Tactic To Retrain Its Employees Instead Of Laying Them Off. Retrieved september 5, 2016, from Business Insider: https://www.businessinsider.in/IBM-Is-Using-An-Unusual-New-Tactic-To-Retrain-Its-Employees-Instead-Of-Laying-Them-Off/articleshow/42913135.cms Huddleston, T. (2015, April 20). IBM's sales decline for twelfth straight quarter. Retrieved September 5, 2016, from Fortune: https://fortune.com/2015/04/20/ibm-earnings-sales-decline/ IBM. (2016, September 5). About Us. Retrieved september 5, 2016, from https://www.ibm.com/ibm/in/en/ IBS Center for Management Research . (2016, September 5). Training Employees of IBM Through e-Learning. Retrieved september 5, 2016, from https://www.icmrindia.org/casestudies/catalogue/Human%20Resource%20and%20Organization%20Behavior/Training%20Employees%20of%20IBM%20Through%20e-Learning.htm National Industry Skill Commitee. (2014). Good Practice Workforce Strategies. National Industry Skill Commitee. Nestle. (2016, September 5). Case Studies. Retrieved sept 5, 2016, from https://www.nestle.in/csv/case-studies Noe, R. A. (2002). Employee Training and Development. McGraw-Hill/Irwin. Resilium. (2016, September 5). Will upskilling staff improve my business? Retrieved september 5, 2016, from https://www.resilium.com.au/advice-centre/staff-resources/will-upskilling-staff-improve-my-business#.V805Nlt961s Upskill America. (2014). A Guide to Upskilling America's Frontline Workers . Upskill America.